Merck and Cerevance collaborate to explore new targets for Alzheimer’s disease
ADC评论
August 11, 2022
On August 10, Merck and Cerevance announced that they have reached a strategic cooperation agreement to use Cerevance’s proprietary NETSseq transcriptomic technology platform to discover
